Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry.

Min S, Lim YS, Shin D, Park C, Park JB, Kim S, Windisch MP, Hwang SB.

Front Microbiol. 2017 Jun 19;8:1129. doi: 10.3389/fmicb.2017.01129. eCollection 2017.

2.

Cracking Ali Baba's code.

Billker O.

Elife. 2017 Jun 14;6. pii: e28600. doi: 10.7554/eLife.28600.

3.

Plasmodium P36 determines host cell receptor usage during sporozoite invasion.

Manzoni G, Marinach C, Topçu S, Briquet S, Grand M, Tolle M, Gransagne M, Lescar J, Andolina C, Franetich JF, Zeisel MB, Huby T, Rubinstein E, Snounou G, Mazier D, Nosten F, Baumert TF, Silvie O.

Elife. 2017 May 16;6. pii: e25903. doi: 10.7554/eLife.25903.

4.

Regulated Entry of Hepatitis C Virus into Hepatocytes.

Miao Z, Xie Z, Miao J, Ran J, Feng Y, Xia X.

Viruses. 2017 May 9;9(5). pii: E100. doi: 10.3390/v9050100. Review.

5.

Hepatitis C virus has a genetically determined lymphotropism through co-receptor B7.2.

Chen CL, Huang JY, Wang CH, Tahara SM, Zhou L, Kondo Y, Schechter J, Su L, Lai MM, Wakita T, Cosset FL, Jung JU, Machida K.

Nat Commun. 2017 Jan 9;8:13882. doi: 10.1038/ncomms13882.

6.

Viral evasion and challenges of hepatitis C virus vaccine development.

Pierce BG, Keck ZY, Foung SK.

Curr Opin Virol. 2016 Oct;20:55-63. doi: 10.1016/j.coviro.2016.09.004. Epub 2016 Sep 19. Review.

PMID:
27657659
7.

A Library of Infectious Hepatitis C Viruses with Engineered Mutations in the E2 Gene Reveals Growth-Adaptive Mutations That Modulate Interactions with Scavenger Receptor Class B Type I.

Zuiani A, Chen K, Schwarz MC, White JP, Luca VC, Fremont DH, Wang D, Evans MJ, Diamond MS.

J Virol. 2016 Nov 14;90(23):10499-10512. Print 2016 Dec 1.

8.

Human Choline Kinase-α Promotes Hepatitis C Virus RNA Replication through Modulation of Membranous Viral Replication Complex Formation.

Wong MT, Chen SS.

J Virol. 2016 Sep 29;90(20):9075-95. doi: 10.1128/JVI.00960-16. Print 2016 Oct 15.

9.

Novel functional hepatitis C virus glycoprotein isolates identified using an optimized viral pseudotype entry assay.

Urbanowicz RA, McClure CP, King B, Mason CP, Ball JK, Tarr AW.

J Gen Virol. 2016 Sep;97(9):2265-79. doi: 10.1099/jgv.0.000537. Epub 2016 Jul 6.

10.

Lipoprotein Receptors Redundantly Participate in Entry of Hepatitis C Virus.

Yamamoto S, Fukuhara T, Ono C, Uemura K, Kawachi Y, Shiokawa M, Mori H, Wada M, Shima R, Okamoto T, Hiraga N, Suzuki R, Chayama K, Wakita T, Matsuura Y.

PLoS Pathog. 2016 May 6;12(5):e1005610. doi: 10.1371/journal.ppat.1005610. eCollection 2016 May.

11.

Hepatitis C virus utilizes VLDLR as a novel entry pathway.

Ujino S, Nishitsuji H, Hishiki T, Sugiyama K, Takaku H, Shimotohno K.

Proc Natl Acad Sci U S A. 2016 Jan 5;113(1):188-93. doi: 10.1073/pnas.1506524113. Epub 2015 Dec 23. Erratum in: Nat Rev Gastroenterol Hepatol. 2016 Apr;13(4):188.

12.

Alcohol and Viral Hepatitis: Role of Lipid Rafts.

Dolganiuc A.

Alcohol Res. 2015;37(2):299-309. Review.

13.

The role of HCV proteins on treatment outcomes.

Kumthip K, Maneekarn N.

Virol J. 2015 Dec 15;12:217. doi: 10.1186/s12985-015-0450-x. Review.

14.

One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1.

Sasso E, Paciello R, D'Auria F, Riccio G, Froechlich G, Cortese R, Nicosia A, De Lorenzo C, Zambrano N.

Biomed Res Int. 2015;2015:703213. doi: 10.1155/2015/703213. Epub 2015 Nov 15.

15.

Host-Targeting Agents to Prevent and Cure Hepatitis C Virus Infection.

Zeisel MB, Crouchet E, Baumert TF, Schuster C.

Viruses. 2015 Nov 2;7(11):5659-85. doi: 10.3390/v7112898. Review.

16.

Novel human anti-claudin 1 mAbs inhibit hepatitis C virus infection and may synergize with anti-SRB1 mAb.

Paciello R, Urbanowicz RA, Riccio G, Sasso E, McClure CP, Zambrano N, Ball JK, Cortese R, Nicosia A, De Lorenzo C.

J Gen Virol. 2016 Jan;97(1):82-94. doi: 10.1099/jgv.0.000330. Epub 2015 Oct 29.

17.

Interferon (IFN) and Cellular Immune Response Evoked in RNA-Pattern Sensing During Infection with Hepatitis C Virus (HCV).

Nakai M, Oshiumi H, Funami K, Okamoto M, Matsumoto M, Seya T, Sakamoto N.

Sensors (Basel). 2015 Oct 23;15(10):27160-73. doi: 10.3390/s151027160. Review.

18.

Chronic hepatitis C virus infection and lipoprotein metabolism.

Aizawa Y, Seki N, Nagano T, Abe H.

World J Gastroenterol. 2015 Sep 28;21(36):10299-313. doi: 10.3748/wjg.v21.i36.10299. Review.

19.

Hepatitis C virus infection: establishment of chronicity and liver disease progression.

Kwon YC, Ray RB, Ray R.

EXCLI J. 2014 Aug 27;13:977-96. eCollection 2014. Review.

20.

Approaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffolding.

He L, Cheng Y, Kong L, Azadnia P, Giang E, Kim J, Wood MR, Wilson IA, Law M, Zhu J.

Sci Rep. 2015 Aug 4;5:12501. doi: 10.1038/srep12501.

Supplemental Content

Support Center